Literature DB >> 27019828

IL-17 and IL-22 genetic polymorphisms in HBV vaccine non- and low-responders among healthcare workers.

Zohreh Borzooy1, Adrian Streinu-Cercel2, Abbass Mirshafiey3, Azam Khamseh4, Masoud Karkhaneh Mahmoudie4, Shadi Sadat Navabi5, Marjan Nosrati6, Zahra Najafi7, Mostafa Hosseini8, Seyed Mohammad Jazayeri9.   

Abstract

BACKGROUND: Healthcare workers constitute a population at high risk for HBV infection. Efficient vaccination options are available; however, the individual response to HBV vaccination may vary widely between subjects, potentially due to cytokine profiles and genetic variations. In the present study, we investigated the relationship between IL-17 and IL-22 gene polymorphisms versus non- and low-responsiveness to HBV vaccination in healthcare workers.
METHODS: We selected the following IL-17 and IL-22 polymorphisms: rs4711998 (A/G) from IL-17 and rs2227501 (A/T), rs2227503 (A/G), rs1026786 (A/G) from IL-22 sequences genes. These were determined by polymerase chain reaction restriction fragment length polymorphisms.
RESULTS: The IL-17 rs4711998 GG genotype had a significantly lower frequency in non-responders compared to low-responders (p=0.025). However, we did not identify a relationship between IL-22 rs1026780, rs2227501 and rs2227503 genotypes and the anti-HBs response following HBV vaccination.
CONCLUSION: These data suggest that genetic variation in rs4711998 polymorphisms in the IL-17 cytokine may influence vaccine-induced immune responses to HBV vaccine in healthcare workers.

Entities:  

Keywords:  HBV vaccine; IL-17; IL-22; gene polymorphisms; healthcare workers

Year:  2016        PMID: 27019828      PMCID: PMC4788777          DOI: 10.11599/germs.2016.1084

Source DB:  PubMed          Journal:  Germs        ISSN: 2248-2997


  39 in total

1.  The nonresponse to hepatitis B vaccination is associated with impaired lymphocyte activation.

Authors:  Loredana Goncalves; Benibelks Albarran; Siham Salmen; Lerida Borges; Howard Fields; Henry Montes; Andres Soyano; Yuleima Diaz; Lisbeth Berrueta
Journal:  Virology       Date:  2004-08-15       Impact factor: 3.616

2.  CD4+ and CD8+ T cell- and IL-17-mediated protection against Entamoeba histolytica induced by a recombinant vaccine.

Authors:  Xiaoti Guo; Lisa Barroso; David M Lyerly; William A Petri; Eric R Houpt
Journal:  Vaccine       Date:  2010-11-21       Impact factor: 3.641

3.  Complex cytokine responses to hepatitis B surface antigen and tetanus toxoid in responders, nonresponders and subjects naive to hepatitis B surface antigen.

Authors:  C E Larsen; J Xu; S Lee; D P Dubey; G Uko; E J Yunis; C A Alper
Journal:  Vaccine       Date:  2000-07-01       Impact factor: 3.641

4.  A proinflammatory role for interleukin-22 in the immune response to hepatitis B virus.

Authors:  Ye Zhang; Melissa A Cobleigh; Jian-Qi Lian; Chang-Xing Huang; Carmen J Booth; Xue-Fan Bai; Michael D Robek
Journal:  Gastroenterology       Date:  2011-06-25       Impact factor: 22.682

5.  IL-17A but not IL-22 suppresses the replication of hepatitis B virus mediated by over-expression of MxA and OAS mRNA in the HepG2.2.15 cell line.

Authors:  Bing Wang; Xin-Ping Zhao; Yu-Chen Fan; Jian-Jun Zhang; Jing Zhao; Kai Wang
Journal:  Antiviral Res       Date:  2012-12-27       Impact factor: 5.970

6.  Impact of IL-22 gene polymorphism on human immunodeficiency virus infection in Han Chinese patients.

Authors:  Jun Hu; Yi Li; Lin Chen; Zhengrong Yang; Guanglu Zhao; Yushu Wang; Jinquan Cheng; Jin Zhao; Ying Peng
Journal:  J Microbiol Immunol Infect       Date:  2014-11-11       Impact factor: 4.399

Review 7.  Recent advances in IL-22 biology.

Authors:  Lauren A Zenewicz; Richard A Flavell
Journal:  Int Immunol       Date:  2011-03       Impact factor: 4.823

8.  Low levels of awareness, vaccine coverage, and the need for boosters among health care workers in tertiary care hospitals in India.

Authors:  Nirupma Trehan Pati; Ankur Sethi; Kireet Agrawal; Kamal Agrawal; Gollapudi Tharun Kumar; Manoj Kumar; Anjur Tupil Kaanan; Shiv Kumar Sarin
Journal:  J Gastroenterol Hepatol       Date:  2008-08-28       Impact factor: 4.029

9.  IL17A gene polymorphisms, serum IL-17A and IgE levels, and hepatocellular carcinoma risk in patients with chronic hepatitis B virus infection.

Authors:  Na Li; Qianqian Zhu; Zhu Li; Qunying Han; Guoyu Zhang; Jinghong Chen; Yi Lv; Fanfan Xing; Yanping Chen; Xiaoyan Zeng; Zhengwen Liu
Journal:  Mol Carcinog       Date:  2012-12-31       Impact factor: 4.784

10.  Influence of IL-10RA and IL-22 polymorphisms on outcome of hepatitis C virus infection.

Authors:  Branwen J Hennig; Angela J Frodsham; Simon Hellier; Susanne Knapp; Leland J Yee; Mark Wright; Lyna Zhang; Howard C Thomas; Mark Thursz; Adrian V Hill
Journal:  Liver Int       Date:  2007-10       Impact factor: 5.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.